Total Payments
$53,194
2024 Payments
$1,908
Companies
44
Transactions
736
Medicare Patients
1,212
Medicare Billing
$156,960
Payment Breakdown by Category
Research$41,331 (77.7%)
Food & Beverage$11,720 (22.0%)
Education$131.69 (0.2%)
Consulting$10.95 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $41,331 | 7 | 77.7% |
| Food and Beverage | $11,720 | 725 | 22.0% |
| Education | $131.69 | 3 | 0.2% |
| Consulting Fee | $10.95 | 1 | 0.0% |
Payments by Type
Research
$41,331
7 transactions
General
$11,863
729 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $32,161 | 5 | $0 (2017) |
| Circassia Pharmaceuticals Inc | $8,494 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $1,780 | 122 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,369 | 74 | $0 (2024) |
| GENZYME CORPORATION | $1,071 | 65 | $0 (2024) |
| CSL Behring | $1,055 | 72 | $0 (2024) |
| F. Hoffmann-La Roche AG | $852.94 | 1 | $0 (2021) |
| PFIZER INC. | $651.29 | 43 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $559.52 | 40 | $0 (2024) |
| Optinose US, Inc. | $559.23 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,908 | 117 | GlaxoSmithKline, LLC. ($306.80) |
| 2023 | $1,763 | 124 | GlaxoSmithKline, LLC. ($427.39) |
| 2022 | $1,528 | 100 | GlaxoSmithKline, LLC. ($265.94) |
| 2021 | $2,903 | 110 | F. Hoffmann-La Roche AG ($852.94) |
| 2020 | $1,220 | 81 | AstraZeneca Pharmaceuticals LP ($215.34) |
| 2019 | $1,325 | 80 | AstraZeneca Pharmaceuticals LP ($282.93) |
| 2018 | $815.40 | 59 | AstraZeneca Pharmaceuticals LP ($200.30) |
| 2017 | $41,731 | 65 | Genentech, Inc. ($32,161) |
All Payment Transactions
736 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Aytu BioPharma, Inc. | Karbinal (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: Pediatric Allergy | ||||||
| 12/18/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/25/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/04/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/24/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Immunology and Neurology | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: GENETIC DISEASE | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| STUDY2 PATIENTS UNCONTROLLED ON ICS 2ND CONTROLLER | Genentech, Inc. | $32,161 | 5 |
| A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis | Circassia Pharmaceuticals Inc | $8,318 | 1 |
| SAFETY AND EFFICACY OF TOCILIZUMAB 4 MGKG OR 8 MGKG IN HOSPITALIZED PATIENTS WITH MODERATE-TO-SEVERE COVID-19 PNEUMONIA A RANDOMIZED CLINICAL TRIAL | F. Hoffmann-La Roche AG | $852.94 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 301 | 2,400 | $106,308 | $41,810 |
| 2022 | 9 | 284 | 1,903 | $81,329 | $36,166 |
| 2021 | 10 | 304 | 2,166 | $89,686 | $42,838 |
| 2020 | 10 | 323 | 2,296 | $86,462 | $36,145 |
Total Patients
1,212
Total Services
8,765
Medicare Billing
$156,960
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 42 | 765 | $22,055 | $10,038 | 45.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 88 | $13,758 | $6,672 | 48.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 41 | 546 | $20,672 | $5,545 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 56 | $12,520 | $5,523 | 44.1% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 22 | 25 | $9,712 | $4,146 | 42.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $8,362 | $3,555 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $7,381 | $3,201 | 43.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 21 | 856 | $11,848 | $3,130 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 110 | $14,520 | $8,016 | 55.2% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 37 | 490 | $13,230 | $6,517 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 51 | $9,690 | $5,283 | 54.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 39 | 463 | $14,816 | $4,611 | 31.1% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 21 | 26 | $9,620 | $4,423 | 46.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $5,130 | $2,597 | 50.6% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 24 | 701 | $9,113 | $2,589 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,640 | $1,840 | 39.7% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2022 | 16 | 19 | $570.00 | $290.74 | 51.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 129 | $16,886 | $9,938 | 58.9% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 34 | 577 | $14,379 | $8,710 | 60.6% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 34 | 516 | $16,512 | $5,217 | 31.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 48 | $9,120 | $4,979 | 54.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 36 | 36 | $6,840 | $3,319 | 48.5% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 16 | 17 | $6,290 | $3,105 | 49.4% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 24 | 787 | $10,231 | $3,031 | 29.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $6,090 | $2,909 | 47.8% |
About Dr. Patrick Perin, MD
Dr. Patrick Perin, MD is a Allergy & Immunology healthcare provider based in Teaneck, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093892465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Perin, MD has received a total of $53,194 in payments from pharmaceutical and medical device companies, with $1,908 received in 2024. These payments were reported across 736 transactions from 44 companies. The most common payment nature is "" ($41,331).
As a Medicare-enrolled provider, Perin has provided services to 1,212 Medicare beneficiaries, totaling 8,765 services with total Medicare billing of $156,960. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Teaneck, NJ
- Active Since 11/01/2006
- Last Updated 10/30/2023
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1093892465
Products in Payments
- Non-Covered Product (Drug) $32,161
- DUPIXENT (Biological) $1,221
- NUCALA (Biological) $930.98
- Actemra (Biological) $852.94
- TRELEGY ELLIPTA (Drug) $728.45
- Haegarda (Biological) $590.87
- Xhance (Drug) $559.23
- Hizentra (Biological) $463.95
- FASENRA (Drug) $363.50
- Xembify (Biological) $337.71
- SYMBICORT (Drug) $321.13
- AUVI-Q (Drug) $305.47
- Xolair (Biological) $300.16
- EUCRISA (Drug) $277.80
- CUVITRU (Biological) $270.46
- TAKHZYRO (Biological) $227.53
- ALVESCO (Drug) $224.87
- CUTAQUIG (Biological) $200.34
- RUCONEST (Biological) $198.78
- Auvi-Q (Drug) $190.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.